Artificial intelligence and biology: AI’s potential for launching a novel era for health and medicine

2026-04-08 · Source: Artificial intelligence (AI) – The Conversation · Field: Health & Wellbeing — Health & Medical Research, Pharmaceuticals & Biotechnology, Life Sciences & Biology · Depth: Intermediate, medium

Summary

Artificial intelligence is revolutionizing biological discovery by enabling scientists to perceive and organize complex biological interactions at scales beyond human innate capabilities. Models like Google DeepMind's AlphaFold, which predicts protein structures, and AlphaGenome, which forecasts gene variant contributions to disease, exemplify this shift. These AI tools are already applied in cancer, Alzheimer's, and pandemic response, accelerating research that traditionally took months or years. While current AI primarily identifies correlations, the field is moving towards hybrid computational frameworks that integrate structured biological knowledge with multi-modal datasets to uncover causal mechanisms. Researchers, such as those at the Arc Institute and the Biernaskie lab, are training AI on vast cellular data and performing perturbations to understand cause-and-effect relationships, aiming to address challenges like regenerative medicine for burn survivors.

Key takeaway

For AI scientists and research teams developing biological models, understanding the shift from correlation to causation is critical. Your focus should evolve towards hybrid computational frameworks that integrate established biological knowledge with diverse multi-modal datasets. This approach, exemplified by perturbation experiments, will enhance model reliability and accelerate the translation of AI insights into practical solutions for complex challenges like regenerative medicine and disease mechanisms.

Key insights

AI is transforming biology by enabling large-scale analysis of complex interactions, moving towards causal understanding.

Principles

• AI excels at perceiving complex biological interactions.
• Correlation-based AI models have context limitations.
• Hybrid models combine structured knowledge with multi-modal data.

Method

Train AI on vast cellular data, perform informed biological perturbations to observe cause-and-effect, and integrate results into model architecture to optimize statistical-causal predictions of cell state.

In practice

• Use AlphaFold for protein structure prediction.
• Apply AlphaGenome for gene variant analysis.
• Explore causal-aware AI for drug discovery.

Topics

• Artificial Intelligence in Biology
• Protein Structure Prediction
• AlphaFold
• AlphaGenome
• Causal Inference

Best for: AI Scientist, Research Scientist, Domain Expert

Related on AIssential

• ‘Virtual cells’ aim to turn raw data into predictive models of biology — Virtual cells utilize AI and vast datasets to simulate cellular behavior for disease and drug discovery.
• The Dog That Hacked Cancer — AI tools can accelerate personalized medicine development, even for non-experts.
• Beyond scaling thesis in biology: Why instrumentation, not compute, sets the ceiling for AI driven biomedicine — Observational limitations, not computational power, currently constrain AI-driven biomedicine's progress.
• Radical Numerics launches with $50M to build general biological intelligence — Multimodal AI models integrating diverse biological data can advance human health through diagnostics and drug discovery while simultaneously bolstering biosecurity.
• From discovery to design: in conversation with Ali Madani (Profluent) — AI-driven language models can design novel, functional proteins from scratch, accelerating biological evolution for therapeutic applications.
• Towards World Models in Biomedical Research — Biomedical world models simulate biological futures by learning intervention-conditioned dynamics from multiscale latent states.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Artificial intelligence (AI) – The Conversation.